https://prabadinews.com/
  • October 10, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Drug Trials Snapshot: RHAPSIDO

Drug Trials Snapshot: RHAPSIDO

RHAPSIDO is a kinase inhibitor that is approved for the treatment of chronic spontaneous urticaria (CSU) in adult patients who remain symptomatic despite H1-antihistamine treatment. Learn more about the drug trials.

administrator

Related Articles